The investment objective of the scheme is to provide returns that, before expenses, correspond to the total returns of the securities as represented by the Constituents of S&P BSE Healthcare Index, subject to tracking error.However, there can be no assurance or guarantee that the investment objective of the Scheme would be achieved.
Expert-managed portfolios tailored to your financial goals and risk appetite.
| ETFs | 1M | 3M | 6M | 9M | 1Y | 2Y | 3Y | 4Y | 5Y | 10Y | ALL |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Fund returns | -7.16% | -4.01% | 10.11% | 12.75% | 6.7% | 4.23% | 19.48% | 19.9% | N/A | N/A | 19.41% |
| Category returns | -2.99% | -4.52% | -3.02% | -5.03% | -4.77% | -2.03% | 9% | 10.98% | 7.45% | 11.5% | N/A |
| Absolute returns | -7.16% | -4.01% | 10.11% | 12.75% | 6.7% | 8.64% | 70.63% | 106.77% | N/A | N/A | 111.68% |
| Rank within category | 256/268 | 64/252 | 2/241 | 4/228 | 14/207 | 13/162 | 1/134 | 5/112 | N/A | N/A | N/A |
| ETFs | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Yearly returns | N/A | 37.59% | 43.8% | -2.93% | 9.41% |
| Q1 returns | N/A | -4.83% | 11.2% | -8.4% | -4.53% |
| Q2 returns | N/A | 17.95% | 5.84% | 6.89% | 18.02% |
| Q3 returns | N/A | 10.76% | 19.44% | -2.47% | 1.75% |
| Q4 returns | -1.34% | 10.66% | 2.3% | 1.66% | -4.57% |
| Alpha | 1.20295 |
| Beta | 0.6777 |
| Sharpe Ratio | 0.297866 |
| Sortino Ratio | 0.633376 |
| R-Squared | 0.3378 |
| Tracking Error | 3.5975 |
| Downside Risk | 17.6208 |
| Std. Deviation (Annualised) | 14.5072 |
| ETFs | 1M | 3M | 6M | 9M | 1Y | 3Y | 5Y | 10Y | ALL | Fund Size (Cr) | Exp. Ratio | Sharpe | Risk |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Motilal Oswal BSE Healthcare ETF Current | -7.16% | -4.01% | 10.11% | 12.75% | 6.7% | 19.48% | N/A | N/A | 19.41% | 44.40 | 0.36 | 0.30 | Very High |
| Nippon India Nifty Pharma ETF | -4.12% | -0.09% | 14.11% | 16.17% | 15.52% | 19.28% | 12.79% | N/A | 12.07% | 1,736.44 | 0.23 | 0.30 | Very High |
| Motilal Oswal BSE Enhanced Value ETF | -3.37% | -6.03% | -9.38% | -9.5% | -0.01% | 18.7% | N/A | N/A | 26.28% | 146.61 | 0.43 | 0.20 | Very High |
| DSP Nifty PSU Bank ETF | -0.29% | -1.08% | -5.84% | -7.11% | 9.24% | 18.66% | N/A | N/A | 20.49% | 1,434.17 | 0.16 | 0.15 | Very High |
| ICICI Prudential Nifty PSU Bank ETF | -0.32% | -1.15% | -6.01% | -7.33% | 8.91% | 18.53% | N/A | N/A | 26.2% | 118.61 | 0.41 | 0.15 | Very High |
| Nippon India ETF Nifty PSU Bank BeES | -0.32% | -1.17% | -6.04% | -7.39% | 8.81% | 18.35% | 25.56% | 10.01% | 6.93% | 3,932.00 | 0.51 | 0.14 | Very High |
| Kotak Nifty PSU Bank ETF | -0.32% | -1.17% | -6.06% | -7.4% | 8.79% | 18.33% | 25.56% | 9.94% | 6.36% | 2,490.74 | 0.51 | 0.14 | Very High |
| Aditya Birla Sun Life Nifty Healthcare ETF | -6.38% | -4.45% | 7.53% | 9.15% | 4.95% | 18.01% | 0% | N/A | 12.85% | 74.67 | 0.20 | 0.27 | Very High |
| ICICI Prudential Nifty Healthcare ETF | -6.38% | -4.44% | 7.56% | 9.19% | 5% | 17.87% | 12.38% | N/A | 12.86% | 231.43 | 0.16 | 0.27 | Very High |
| CPSE Exchange Traded Scheme | -4.68% | -8.11% | -17.4% | -5.64% | -6.14% | 17.73% | 22.49% | 13.23% | 13.75% | 18,645.20 | 0.08 | 0.19 | Very High |
| Name | Sector | Instrument | Assets % |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 12.33% |
| Divi's Laboratories Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 7.42% |
| Apollo Hospitals Enterprise Ltd. | Healthcare Services | Domestic Equities | 5.21% |
| Laurus Labs Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 4.84% |
| Cipla Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 4.79% |
| Dr. Reddy's Laboratories Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 4.73% |
| Max Healthcare Institute Ltd. | Healthcare Services | Domestic Equities | 4.32% |
| Torrent Pharmaceuticals Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 3.55% |
| Lupin Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 3.11% |
| Aurobindo Pharma Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 2.89% |
| Fortis Healthcare Ltd. | Healthcare Services | Domestic Equities | 2.51% |
| Glenmark Pharmaceuticals Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 2.17% |
| Alkem Laboratories Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 1.89% |
| Zydus Lifesciences Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 1.82% |
| Mankind Pharma Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 1.75% |
| Ipca Laboratories Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 1.69% |
| Biocon Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 1.63% |
| Gland Pharma Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 1.44% |
| Sai Life Sciences Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 1.30% |
| Krishna Institute of Medical Sciences Ltd | Healthcare Services | Domestic Equities | 1.24% |
| Aster DM Quality Care Ltd. | Healthcare Services | Domestic Equities | 1.18% |
| Neuland Laboratories Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 1.16% |
| Wockhardt Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 1.10% |
| Acutaas Chemicals Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 1.06% |
| Ajanta Pharma Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 1.02% |
| Dr. Lal Pathlabs Ltd. | Healthcare Services | Domestic Equities | 0.96% |
| Abbott India Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.87% |
| Piramal Pharma Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.81% |
| Narayana Hrudayalaya Ltd. | Healthcare Services | Domestic Equities | 0.78% |
| Shilpa Medicare Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.77% |
| Granules India Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.76% |
| Global Health Ltd. | Healthcare Services | Domestic Equities | 0.76% |
| Onesource Specialty Pharma Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.75% |
| Glaxosmithkline Pharmaceuticals Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.71% |
| Rubicon Research Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.67% |
| Anthem Biosciences Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.58% |
| Jubilant Pharmova Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.51% |
| Emcure Pharmaceuticals Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.51% |
| Strides Pharma Science Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.47% |
| Natco Pharma Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.46% |
| Cohance Lifesciences Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.45% |
| Vijaya Diagnostic Centre Ltd. | Healthcare Services | Domestic Equities | 0.45% |
| Syngene International Ltd. | Healthcare Services | Domestic Equities | 0.43% |
| Marksans Pharma Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.43% |
| Rainbow Children's Medicare Ltd. | Healthcare Services | Domestic Equities | 0.42% |
| Poly Medicure Ltd. | Healthcare Equipment & Supplies | Domestic Equities | 0.39% |
| Indegene Ltd. | Healthcare Services | Domestic Equities | 0.38% |
| Eris Lifesciences Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.38% |
| Pfizer Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.37% |
| Metropolis Healthcare Ltd. | Healthcare Services | Domestic Equities | 0.36% |
| Caplin Point Laboratories Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.34% |
| Aarti Pharmalabs Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.31% |
| Jupiter Life Line Hospitals Ltd. | Healthcare Services | Domestic Equities | 0.30% |
| Concord Biotech Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.29% |
| Bliss GVS Pharma Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.29% |
| Alembic Pharmaceuticals Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.29% |
| Procter & Gamble Health Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.28% |
| Yatharth Hospital & Trauma Care Services Ltd. | Healthcare Services | Domestic Equities | 0.27% |
| Morepen Laboratories Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.27% |
| Alivus Life Sciences Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.27% |
| CORONA Remedies Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.25% |
| Astrazeneca Pharma India Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.24% |
| Viyash Scientific Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.23% |
| Dr. Agarwal's Health Care Ltd. | Healthcare Services | Domestic Equities | 0.23% |
| Healthcare Global Enterprises Ltd. | Healthcare Services | Domestic Equities | 0.22% |
| Senores Pharmaceuticals Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.22% |
| Thyrocare Technologies Ltd. | Healthcare Services | Domestic Equities | 0.21% |
| Akums Drugs & Pharmaceuticals Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.18% |
| Kovai Medical Center & Hospital Ltd. | Healthcare Services | Domestic Equities | 0.17% |
| Sanofi India Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.17% |
| Sanofi Consumer Healthcare India Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.16% |
| Supriya Lifescience Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.15% |
| Nephrocare Health Services Ltd. | Healthcare Services | Domestic Equities | 0.15% |
| Suven Life Sciences Ltd. | Healthcare Services | Domestic Equities | 0.15% |
| IOL Chemicals And Pharmaceuticals Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.15% |
| Blue Jet Healthcare Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.13% |
| Park Medi World Ltd. | Healthcare Services | Domestic Equities | 0.13% |
| Ind-Swift Laboratories Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.12% |
| Sun Pharma Advanced Research Company Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.12% |
| Innova Captab Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.12% |
| Solara Active Pharma Sciences Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.11% |
| Artemis Medicare Services Ltd. | Healthcare Services | Domestic Equities | 0.11% |
| Net Receivables / (Payables) | Cash & Cash Equivalents and Net Assets | 0.10% | |
| FDC Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.10% |
| Kwality Pharmaceuticals Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.10% |
| Indraprastha Medical Corporation Ltd. | Healthcare Services | Domestic Equities | 0.10% |
| Aarti Drugs Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.10% |
| Orchid Pharma Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.10% |
| SMS Pharmaceuticals Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.09% |
| Evonile Pharma Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.09% |
| Venus Remedies Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.09% |
| Shukra Medtech Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.08% |
| Advanced Enzyme Technologies Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.08% |
| RPG Life Sciences Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.08% |
| Gujarat Themis Biosyn Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.08% |
| Gufic Biosciences Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.07% |
| Syncom Formulations (India) Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.07% |
| Unichem Laboratories Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.07% |
| Krsnaa Diagnostics Ltd. | Healthcare Services | Domestic Equities | 0.06% |
| Dishman Carbogen Amcis Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.06% |
| Fredun Pharmaceuticals Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.06% |
| Indoco Remedies Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.06% |
| Vimta Labs Ltd. | Healthcare Services | Domestic Equities | 0.06% |
| Anlon Healthcare Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.05% |
| 3B Blackbio Dx Ltd. | Healthcare Services | Domestic Equities | 0.05% |
| Hester Biosciences Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.05% |
| Windlas Biotech Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.05% |
| Fischer Medical Ventures Ltd. | Healthcare Equipment & Supplies | Domestic Equities | 0.05% |
| Hikal Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.05% |
| Amrutanjan Health Care Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.05% |
| Kopran Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.05% |
| Suraksha Diagnostic Ltd. | Healthcare Services | Domestic Equities | 0.04% |
| Sigachi Industries Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.04% |
| KMC Speciality Hospitals (India) Ltd. | Healthcare Services | Domestic Equities | 0.04% |
| Sai Parenteral's Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.04% |
| Dr Agarwals Eye Hospital Ltd. | Healthcare Services | Domestic Equities | 0.04% |
| Panacea Biotec Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.04% |
| Lincoln Pharmaceuticals Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.04% |
| Fermenta Biotech Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.03% |
| Tarsons Products Ltd. | Healthcare Equipment & Supplies | Domestic Equities | 0.03% |
| NGL Fine-Chem Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.03% |
| GPT Healthcare Ltd. | Healthcare Services | Domestic Equities | 0.03% |
| Bajaj Healthcare Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.03% |
| Jagsonpal Pharmaceuticals Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.03% |
| Gujarat Kidney And Super Speciality Ltd. | Healthcare Services | Domestic Equities | 0.02% |
| Wanbury Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.02% |
| Shalby Ltd. | Healthcare Services | Domestic Equities | 0.02% |
| Laxmi Dental Ltd. | Healthcare Equipment & Supplies | Domestic Equities | 0.02% |
| Themis Medicare Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.02% |
| One Global Service Provider Ltd. | Healthcare Services | Domestic Equities | 0.02% |
| Kilitch Drugs (India) Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.02% |
| Medicamen Biotech Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.02% |
| Anuh Pharma Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.02% |
| Gaudium IVF and Women Health Ltd. | Healthcare Services | Domestic Equities | 0.01% |
| Fabtech Technologies Ltd. | Healthcare Equipment & Supplies | Domestic Equities | 0.01% |
| Ambalal Sarabhai Enterprises Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.01% |
| Take Ltd. | Healthcare Services | Domestic Equities | 0.01% |
| Gennex Laboratories Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.01% |
| Medico Remedies Ltd. | Pharmaceuticals & Biotechnology | Domestic Equities | 0.00% |
| Total | 100.00% | ||
Mr. Swapnil Mayekar has more than 10 years of overall experience in the financial services industry. He has been part of fund management & product development team for Motilal Oswal Asset Management Company Ltd. Mr. Mayekar's key area of expertise is trading in equity and debt segment, quantitative analysis, creating customized indices, model testing and building research database. His last assignment was with Business Standard Limited as a Research Associate. He has done his post-graduation in Commerce (Finance Management) from University of Mumbai.
Mr. Rakesh Shetty has more than 13 years of overall experience and expertise in trading in equity, debt segment, Exchange Trade Fund’s management, Corporate Treasury and Banking. Prior to joining Motilal Oswal Asset Management Company Limited, he has worked with Company engaged in Capital Market Business wherein he was in charge of equity and debt ETFs, customized indices and has also been part of product development.
Mr. Dishant Mehta has more than 9 years of experience and expertise in Financial markets across different segment- Equities, Derivatives, Commodities and Currencies. Managed Institutional and Foreign Portfolio Investment clients.
Get personalized portfolio management services designed to grow and protect your wealth.
ChatGPT
Claude
Perplexity
